[1] |
张新宝, 周瑛, 姚超, 等.结核感染T细胞斑点试验诊断胸腔积液的价值[J].实用医学杂志, 2019, 35(9):1492- 1495. DOI: 10.3969/j.issn.1006-5725.2019.09.031.ZHANG XB, ZHOU Y, YAO C, et al. Value of T-spot. TB test in diagnosis of pleural effusion[J]. J Pract Med, 2019, 35(9):1492-1495. DOI:10.3969/j.issn.1006-5725. 2019.09.031.
|
[2] |
MUÑOZ P, RODRÍGUEZ C, BOUZA E. Mycobacterium tuberculosis infection in recipients of solid organ transplants[J]. Clin Infect Dis, 2005, 40(4):581-587. DOI: 10.1086/427692.
|
[3] |
DOWDY DW, BASU S, ANDREWS JR. Is passive diagnosis enough? the impact of subclinical disease on diagnostic strategies for tuberculosis[J]. Am J Respir Crit Care Med, 2013, 187(5):543-551. DOI:10.1164/ rccm.201207-1217OC.
|
[4] |
WU W, YANG M, XU M, et al. Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China[J]. PLoS One, 2018, 13(4):e0195695. DOI:10.1371/journal. pone.0195695.
|
[5] |
MARQUES ID, AZEVEDO LS, PIERROTTI LC, et al. Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade[J]. Clin Transplant, 2013, 27(2):E169-E176. DOI:10.1111/ ctr.12077.
|
[6] |
VIANA LA, CRISTELLI MP, SANTOS DW, et al.Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: a retrospective cohort analysis[J]. Am J Transplant, 2019, 19(5):1421-1431. DOI: 10.1111/ajt.15220.
|
[7] |
CALAROTA SA, ZELINI P, DE SILVESTRI A, et al. Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients[J]. Transplantation, 2012, 93(1):112-119. DOI: 10.1097/TP.0b013e318239e90c.
|
[8] |
PAI M, DENKINGER CM, KIK SV, et al. Gamma interferon release assays for detection of mycobacterium tuberculosis infection[J]. Clin microbiol Rev, 2014, 27(1):3-20. DOI: 10.1128/CMR.00034-13.
|
[9] |
JAMBALDORJ E, HAN M, JEONG JC, et al. Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country[J]. BMC Nephrol, 2017, 18(1):88. DOI:10.1186/s12882-017- 0506-9.
|
[10] |
GIACOMELLI IL, SCHUHMACHER NETO R, MARCHIORI E, et al. Chest X-ray and chest CT findings in patients diagnosed with pulmonary tuberculosis following solid organ transplantation: a systematic review[J]. J Bras Pneumol, 2018, 44(2):161-166. DOI:10.1590/s1806- 37562017000000459.
|
[11] |
NATORI Y, FERREIRA VH, NELLIMARLA S, et al. Incidence, outcomes, and long-term immune response to tuberculosis in organ transplant recipients[J]. Transplantation, 2019, 103(1):210-215. DOI:10.1097/ TP.0000000000002340.
|
[12] |
LI G, YANG F, HE X, et al. Anti-tuberculosis (TB) chemotherapy dynamically rescues Th1 and CD8+ T effector levels in Han Chinese pulmonary TB patients[J]. Microbes Infect, 2020, 22(3):119-126. DOI:10.1016/ j.micinf.2019.10.001.
|
[13] |
CACCAMO N, PIETRA G, SULLIVAN LC, et al. Human CD8 T lymphocytes recognize mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines[J]. Eur J Immunol, 2015, 45(4):1069-1081. DOI:10.1002/ eji.201445193.
|
[14] |
MCMURTREY C, HARRIFF MJ, SWARBRICK GM, et al. T cell recognition of mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells[J]. PLoS One, 2017, 12(11):e0188288. DOI:10.1371/ journal.pone.0188288.
|
[15] |
PREZZEMOLO T, VAN MEIJGAARDEN KE, FRANKEN KLMC, et al. Detailed characterization of human mycobacterium tuberculosis specific HLA-E restricted CD8+ T cells[J]. Eur J Immunol, 2018, 48(2):293-305. DOI: 10.1002/eji.201747184.
|
[16] |
GRANT EJ, NGUYEN AT, LOBOS CA, et al. The unconventional role of HLA-E: the road less traveled[J]. Mol Immunol, 2020, 120:101-112. DOI:10.1016/j.molimm. 2020.02.011.
|
[17] |
VAN MEIJGAARDEN KE, HAKS MC, CACCAMO N, et al. Human CD8+ T-cells recognizing peptides from mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset[J]. PLoS Pathog, 2015, 11(3):e1004671. DOI: 10.1371/journal.ppat.1004671.
|
[18] |
TAMBUNAN BA, PRIYANTO H, NUGRAHA J, et al. CD4+ and CD8+ T-cells expressing interferon gamma in active pulmonary tuberculosis patients[J]. Afr J Infect Dis, 2018, 12(1 Suppl):49-53. DOI: 10.2101/Ajid.12v1S.6.
|
[19] |
YANG JD, MOTT D, SUTIWISESAK R, et al. Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages[J]. PLoS Pathog, 2018, 14(5):e1007060. DOI: 10.1371/journal.ppat.1007060.
|
[20] |
HERZMANN C, DALLENGA T, KALINKE U. Pulmonary immune mechanisms in tuberculosis[J]. Pneumologie, 2018, 72(7):493-502. DOI: 10.1055/s-0043-122961.
|
[21] |
LIN PL, FLYNN JL. CD8 T cells and mycobacterium tuberculosis infection[J]. Semin Immunopathol, 2015, 37(3):239-249. DOI: 10.1007/s00281-015-0490-8.
|
[22] |
LAZAREVIC V, FLYNN J. CD8+ T cells in tuberculosis[J]. Am J Respir Crit Care Med, 2002, 166(8):1116-1121. DOI: 10.1164/rccm.2204027.
|
[23] |
PALLET N, FERNÁNDEZ-RAMOS AA, LORIOT MA. Impact of immunosuppressive drugs on the metabolism of T cells[J]. Int Rev Cell Mol Biol, 2018, 341:169-200. DOI: 10.1016/bs.ircmb.2018.05.009.
|
[24] |
FERNÁNDEZ-RAMOS AA, POINDESSOUS V, MARCHETTI-LAURENT C, et al. The effect of immunosuppressive molecules on T-cell metabolic reprogramming[J]. Biochimie, 2016, 127:23-36. DOI: 10.1016/j.biochi.2016.04.016.
|
[25] |
WANG J, DAI Y, LIU J, et al. MTB-specific lymphocyte responses are impaired in tuberculosis patients with pulmonary cavities[J]. Eur J Med Res, 2017, 22(1):4. DOI: 10.1186/s40001-016-0242-9.
|